Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.
Local Bounti Corp (NYSE:LOCL) reported second-quarter FY22 sales of $6.27 million, beating the consensus of $5.25 million. The company reported $0.108…